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Evaluating the Impact of VevoVitall and/or CRINA as Potential Porcine Epidemic
Diarrhea Virus Mitigation Strategies as Determined by Polymerase Chain
Reaction Analysis and Bioassay
Abstract
Feed and feed ingredients have been shown to be potential vectors of porcine epidemic diarrhea virus
(PEDV). Potential strategies to mitigate the risk of disease transmission via feed and feed ingredients
would be valuable to the swine and feed milling industries. Therefore, the objective of this experiment was
to determine the impact of VevoVitall (5,000 ppm; DSM Nutritional Products Inc., Parsipanny, NJ), CRINA
(200 ppm; DSM Nutritional Products Inc., Parsipanny, NJ), and a combination of both products
(COMBINATION; 5,000 ppm VevoVitall and 200 ppm CRINA) as feed additives with potential to mitigate
the risk of PEDV, in swine gestation diet (FEED) and spraydried porcine plasma (SDPP) as determined by
real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analyzed at seven
sampling days post laboratory inoculation (d 0, 1, 3, 7, 14, 21, and 42) and bioassay. There was a
marginally significant treatment × feed matrix × day interaction (P = 0.082), in which the cycle threshold
(Ct) value increased over time in the diet when treated with the COMBINATION, whereas, there was no
increase over time observed in SDPP. There was a highly significant (P < 0.001) feed matrix × day
interaction in which the Ct increased over time in FEED, whereas, there was very little increase over time
observed in SDPP. Additionally, there was a marginally significant treatment × feed matrix interaction (P =
0.079). Overall, the COMBINATION was most effective at reducing the quantity of genetic material as
detected by qRT-PCR (P < 0.001). Virus shedding was observed in the d 7 post-inoculation SDPP
COMBINATION treatment, as well as d 0 FEED COMBINATION treatment. No other treatment bioassay
room had detectable RNA shed and detected in fecal swabs or cecal contents (d 1, 3, 7, 14, and 21 postlaboratory inoculation FEED, COMBINATION).
In summary, the combination of CRINA and VevoVitall enhanced degradation of PEDV RNA in swine feed,
but had no impact on RNA degradation in SDPP. Furthermore, both untreated feed and feed treated with
the combination of CRINA and VevoVitall caused infection at d 0 post-laboratory inoculation; however,
neither set of samples was infective at d 1 post-laboratory inoculation.
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Summary

Feed and feed ingredients have been shown to be potential vectors of porcine epidemic
diarrhea virus (PEDV). Potential strategies to mitigate the risk of disease transmission
via feed and feed ingredients would be valuable to the swine and feed milling industries.
Therefore, the objective of this experiment was to determine the impact of VevoVitall
(5,000 ppm; DSM Nutritional Products Inc., Parsipanny, NJ), CRINA (200 ppm;
DSM Nutritional Products Inc., Parsipanny, NJ), and a combination of both products
(COMBINATION; 5,000 ppm VevoVitall and 200 ppm CRINA) as feed additives
with potential to mitigate the risk of PEDV, in swine gestation diet (FEED) and spraydried porcine plasma (SDPP) as determined by real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analyzed at seven sampling days post
laboratory inoculation (d 0, 1, 3, 7, 14, 21, and 42) and bioassay. There was a marginally
significant treatment × feed matrix × day interaction (P = 0.082), in which the cycle
threshold (Ct) value increased over time in the diet when treated with the COMBINATION, whereas, there was no increase over time observed in SDPP. There was a
highly significant (P < 0.001) feed matrix × day interaction in which the Ct increased
over time in FEED, whereas, there was very little increase over time observed in SDPP.
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Mary Muckey for technical support.
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Additionally, there was a marginally significant treatment × feed matrix interaction (P
= 0.079). Overall, the COMBINATION was most effective at reducing the quantity
of genetic material as detected by qRT-PCR (P < 0.001). Virus shedding was observed
in the d 7 post-inoculation SDPP COMBINATION treatment, as well as d 0 FEED
COMBINATION treatment. No other treatment bioassay room had detectable RNA
shed and detected in fecal swabs or cecal contents (d 1, 3, 7, 14, and 21 post-laboratory
inoculation FEED, COMBINATION).
In summary, the combination of CRINA and VevoVitall enhanced degradation
of PEDV RNA in swine feed, but had no impact on RNA degradation in SDPP.
Furthermore, both untreated feed and feed treated with the combination of CRINA
and VevoVitall caused infection at d 0 post-laboratory inoculation; however, neither set
of samples was infective at d 1 post-laboratory inoculation.
Key words: feed additive, feed matrix, PEDV, swine

Introduction

Feed and feed ingredients have been shown to be potential vectors of Porcine Epidemic
Diarrhea virus (PEDV).7,8 Therefore, potential strategies to mitigate the risk of disease
transmission via feed and feed ingredients would be valuable to the swine and feed
manufacturing industries. Research has been conducted assessing potential mitigation
techniques, such as the use of certain feed additives or thermal processing during pelleting of diets. During the pelleting of complete swine diets, previous research has shown
that a pelleting conditioner temperature of 130°F was effective at minimizing the risk of
PEDV transfer.9 The application of certain feed additives, including medium chain fatty
acids, essential oils, organic acids, and formaldehyde, has been effective at degrading
PEDV genetic material in complete feed and feed ingredients as quantified by quantitative real-time polymerase chain reaction (qRT-PCR), but lack of infectivity has not
been verified via bioassay.10
CRINA and VevoVitall are two commercially available products sold by DSM Nutritional Products (Parsipanny, NJ). CRINA is a combination of essential oils designed to
stimulate gut health in swine, and VevoVitall is a 99.9% benzoic acid product designed
Dee, S., T. Clement, A. Schelkopf, J. Nerem, D. Knudsen, J. Christopher-Hennings, and E. Nelson.
2014. An evaluation of contaminated complete feed as a vehicle for porcine epidemic diarrhea virus
infection of naive pigs following consumption via natural feeding behavior: Proof of concept. BMC
Veterinary Research. 10(176).
8
Pillatzki, A. E., P. C. Gauger, D. M. Madson, E. R. Burrough, JianQiang Zhang, Q. Chen, D. R. Magstadt, P. H. E. Arruda, G. W. Stevenson, and K. J. J. Yoon. 2015. Experimental inoculation of neonatal
piglets with feed naturally contaminated with porcine epidemic diarrhea virus. Journal of Swine Health
and Production. 23(6): 317-320.
9
Cochrane, R. A., S. S. Dritz, J. C. Woodworth, A. R. Huss, C. R. Stark, R. A. Hesse, JianQiang Zhang,
M. D. Tokach, J. Bai, and C. K. Jones. 2015. Evaluating chemical mitigation of Porcine Epidemic Diarrhea Virus (PEDV) in swine feed and ingredients. Kansas State University Swine Day 2015. Kansas
Agricultural Experiment Station Research Reports. Vol. 1: Iss. 7.
10
Cochrane, R. A., L. L. Schumacher, S. S. Dritz, J. C. Woodworth, A. R. Huss, C. R. Stark, J. M.
DeRouchey, M. D. Tokach, R. D. Goodband, J. Bai, Q. Chen, JianQiang Zhang, P. C. Gauger, R. G.
Main, and C. K. Jones. 2015. Effect of thermal mitigation on Porcine Epidemic Diarrhea Virus (PEDV)contaminated feed. Kansas State University Swine Day 2015. Kansas Agricultural Experiment Station
Research Reports. Vol. 1: Iss. 7.
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to reduce activity of microorganisms in feed, including fungi, yeasts and certain bacteria,
such as E. coli and Salmonella.11 However, neither CRINA nor VevoVitall have been
tested as potential PEDV mitigants. Therefore, the objective of this experiment was to
determine the impact of VevoVitall and CRINA as feed additives with the potential to
mitigate PEDV contamination of feed and spray-dried porcine plasma as determined by
real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and
bioassay.

Procedures

Treatment structure was designed in a 2 × 2 × 2 factorial arrangement with two feed
matrices (FEED and SDPP) and feed additive treatment factors including VevoVitall
(5,000 ppm; DSM Nutritional Products Inc., Parsippany, NJ) and CRINA (200 ppm;
DSM Nutritional Products Inc., Parsippany, NJ), and combination of both products
(COMBINATION; 5,000 ppm VevoVitall and 200 ppm CRINA). The swine diet
(Table 1) used in this experiment was manufactured at the Kansas State University
O.H. Kruse Feed Technology Innovation Center in Manhattan, KS, and was verified to
be devoid of PEDV and porcine delta-coronavirus (PDCoV) ribonucleic acid (RNA)
as determined via qRT-PCR prior to initiation of the experiment. Spray-dried porcine
plasma (APC Functional Proteins, Ankeny, IA) was also verified to be free of both
PEDV and delta-coronavirus RNA prior to use as verified by qRT-PCR.

Feed Additive Treatment

Prior to treatment of feed matrices with feed additive treatments, a 25.0 g sample
of each feed matrix was collected and placed in its appropriate bottle. These samples
received no virus, and were the positive control samples reserved for the bioassay portion of the experiment. A benchtop paddle mixer was used as previously described12 for
mixing dry products with FEED. Mixing time was 3 min, as was previously verified with
a CV of < 10% using a chloride mixer efficiency procedure (Quantab; Hach Co., Loveland, CO). A V-mixer (Cross-Flow Blender; Patterson-Kelley Co., East Stroudsburg,
PA) was used to mix feed additive treatments with SDPP. A mixer efficiency test was
performed using spray-dried bovine plasma, and resulted in a uniform mix with a mix
time of 7.0 min (MicroTracer-F; Microtracers Inc., San Francisco, CA).
Following the mixing of feed matrix and corresponding feed additive treatment, 22.5 g
of chemically treated feed matrix was sampled and placed in the appropriate bottle (250
mL Nalgene square wide-mouth HDPE; Thermo Fisher Scientific, Waltham, MA) to
be inoculated with PEDV and analyzed on seven sampling days post laboratory inoculation (d 0, 1, 3, 7, 14, 21, and 42), with 3 replications of each sampling day/feed additive
treatment combination. This process was repeated for each feed matrix × feed additive
treatment combination. Both the paddle mixer and V-blender were cleaned between
feed additive treatments initially by high-pressure air, then a flush step was performed
DSM Nutritional Products, Inc., Parsippany, NJ; http://www.dsm.com/markets/anh/en_US/products/products-eubiotics/products-eubiotics-vevovitall.html, Accessed 1/13/2016.
12
Schumacher, L. L., J. C. Woodworth, C. R. Stark, C. K. Jones, R. A. Hesse, R. G. Main, Jianqiang
Zhang, P. C. Gauger, S. S. Dritz, and M. D. Tokach. 2015. Determining the minimum infectious dose
of Porcine Epidemic Diarrhea Virus (PEDV) in a feed matrix. Kansas State University Swine Day 2015.
Kansas Agricultural Experiment Station Research Reports. Vol. 1: Iss. 7.
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with either untreated FEED or SDPP for the paddle mixer and V-blender, respectively,
followed by a final cleaning with high-pressure air.

Inoculation

Inoculation was carried out at the Kansas State University College of Veterinary
Medicine Virology Laboratory. The viral inoculum was cell culture derived USA/
IN/2013/19338, passage 8 and had an initial concentration of 106 TCID50/mL. Fifty
mL of concentrated inoculum was mixed with 450 mL of tissue culture media, resulting
in a diluted inoculum concentration of 105 TCID50/mL. Inoculation occurred by pipetting 2.5 mL of diluted viral inoculum into each bottle containing 22.5 g feed matrix, resulting in an inoculated feed matrix with a viral concentration of 104 TCID50/g of feed
matrix. Following addition of the viral inoculum to each bottle, the bottles were lightly
shaken in a circular pattern for approximately five seconds, after which each bottle was
vigorously hand shaken for approximately 10 sec to mix the virus evenly within each
bottle.

Real-time PCR analysis

Separate bottles were analyzed on d 0, 1, 3, 7, 14, 21, and 42 post-laboratory inoculation. On each day of analysis, 100 mL phosphate buffered saline (PBS; pH 7.4 1X, Life
Technologies, Grand Island, NY) was added to each bottle predetermined for analysis
on that day. Bottles were shaken for approximately 10 sec, at which point they were
allowed to settle overnight at 39.2°F. The following day, supernatant was pulled and aliquoted for further analysis. A total of 4 aliquots from each sample bottle were collected
and stored at -4°F until the conclusion of the trial, at which point qRT-PCR analysis
was performed on one aliquot per sample bottle and the remaining three samples per
bottle were stored at -112°F until transported to Iowa State University for the initiation of the bioassay portion of the experiment.
After collection of d 42 post-laboratory inoculation aliquots, qRT-PCR was conducted
on designated preserved aliquots at Kansas State University Veterinary Diagnostic
Laboratory Molecular Diagnostics Lab as previously described.12 Fifty microliters (µL)
of supernatant from each sample was loaded into a deep well plate and extracted using
a Kingfisher 96 magnetic particle processor (Fisher Scientific, Pittsburg, PA) and the
MagMAX-96 Viral RNA Isolation kit (Life Technologies, Grand Island, NY) according to the manufacturer’s instructions with one modification, reducing the final elution
volume to 60 µL. One negative extraction control consisting of all reagents except the
sample was included in each extraction. The extracted RNA was frozen at -4°F until
assayed by qRT-PCR. Analyzed values represent cycle threshold (Ct) at which virus
was detected. A greater Ct value indicates more cycles must proceed until viral genetic
material is detected, thus lower quantities of genetic material are present in the original
sample.

Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Bioassay

A bioassay was performed using selected treatment × time combinations at Iowa State
University Veterinary Diagnostic Laboratory to determine the viral infectivity characteristics following protocols previously described by Pillatzki et al., 201513 and Thomas
et al., 2015.14
The experimental protocol for the pig bioassay portion of the experiment was reviewed
and approved by the Iowa State University Institutional Animal Care and Use Committee. Forty-eight crossbred, 10 d-old pigs of mixed sex were sourced from a single
commercial, crossbred farrow-to-wean herd with no prior exposure to PEDV. Upon
arrival, piglets were ear tagged, weighed, and administered a dose of cefitiofur (Excede,
Zoetis, Florham Park, NJ). Also upon arrival, fecal swabs were obtained and confirmed
negative for PEDV, porcine delta coronavirus (PDCoV), and transmissible gastroenteritis virus (TGEV) using a qRT-PCR assay. To further confirm PEDV negative
status, serum was collected and confirmed negative for PEDV antibody by an indirect
fluorescent antibody (IFA) assay and TGEV antibody by enzyme-linked immunosorbent assay (ELISA) conducted at the Iowa State University Veterinary Diagnostic
Laboratory (ISU-VDL). Pigs were allowed 2 d of adjustment to the new pens before the
bioassay began.
Briefly, pigs from each experimental treatment were housed in separate rooms with
independent ventilation systems. Rooms had solid flooring that was minimally rinsed
to reduce risk of PEDV aerosolization. Pigs were fed liquid milk replacer twice daily and
offered a commercial pelleted swine diet ad libitum with free access to water. Each pig
was administered 10 mL of the PBS supernatant treatment by orogastric gavage using
an 8-gauge French catheter 0 d post-bioassay inoculation (dpi).
Rectal swabs were collected on d -2, 0, 2, 4, and 6 dpi from all piglets and tested for
PEDV RNA via qRT-PCR. Fresh small intestine, cecum, and colon were collected at
necropsy at 7 dpi, along with an aliquot of cecal content. One section of formalin-fixed
proximal, middle, and distal jejunum and ileum were collected for histopathology.
Cecal content was evaluated for PEDV via qRT-PCR. Tissue was routinely processed
and fixed in neutral buffered formalin, embedded, sectioned, and stained with
hematoxylin and eosin stain. One section of proximal, middle, and distal jejunum; and
three serial sections from the piece of ileum (for a total of six sections of intestine) were
evaluated by a veterinary pathologist blind to the treatments. Morphology and IHC
data were excluded from the current report.

Pillatzki, A. E., P. C. Gauger, D. M. Madson, E. R. Burrough, Zhang JianQiang, Q. Chen, D. R. Magstadt, P. H. E. Arruda, G. W. Stevenson, and K. J. J. Yoon. 2015. Experimental inoculation of neonatal
piglets with feed naturally contaminated with porcine epidemic diarrhea virus. Journal of Swine Health
and Production. 23(6): 317-320.
14
Thomas, J. T., Qi Chen, P. C. Gauger, L. G. Gimenez-Lirola, Avanti Sinha, K. M. Harmon, D. M.
Madson, E. R. Burrough, D. R. Magstadt, H. M. Salzbrenner, M. W. Welch, Yoon Kyoung-Jin, J. J.
Zimmerman, and Zhang Jian Qiang. 2015. Effect of porcine epidemic diarrhea virus infectious doses on
infection outcomes in naive conventional neonatal and weaned pigs. PLOS ONE. 10(10): e0139266.
13
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Statistical Analysis

Data were analyzed using PROC GLIMMIX (SAS Institute, Inc., Cary, NC) to determine the main effects of feed additive treatment, feed matrix, as well as day post-laboratory inoculation and all associated interactions on PEDV Ct values with individual
sample bottle as the experimental unit. Bottle within treatment was included in the
model as the subject of the repeated measure of day after laboratory inoculation. Bottle
was included in the statistical model as a random effect. Results for the response criteria
were considered significant at P ≤ 0.05 and marginally significant from P > 0.05 to
P ≤ 0.10.

Results and Discussion

Quantity of Detectable Viral RNA

There was a marginally significant treatment × feed matrix × day interaction
(P = 0.082, Table 2) in which the combination of CRINA and VevoVitall resulted in
a reduction of quantifiable RNA on d 21 and 42 at a greater rate in feed than in the
SDPP matrix. There was a significant (P < 0.001, Table 2) feed matrix × day interaction
in which the Ct value increased over time in gestation diet, whereas there was very little
increase over time observed in SDPP. Additionally, there was a marginally significant
treatment × feed matrix interaction (P = 0.079, Table 3) in which the combination
of CRINA and VevoVitall was more effective at reducing the amount of quantifiable
RNA in FEED relative to no feed additive treatment or feed additives included individually, and was no different than untreated or treatment with CRINA or VevoVitall
individually in the SDPP matrix. There was no treatment × day interaction (P = 0.234).
All main effects were highly significant, including treatment, day, and feed matrix (P ≤
0.003, Tables 2 and 3). Overall, the combination of CRINA and VevoVitall was most
effective at reducing the quantity of genetic material (P < 0.001, Ct = 33.0; Table 3),
regardless of feed matrix or day post-inoculation. All three feed samples treated with
the COMBINATION did not have detectable PEDV RNA at d 42 post-laboratory
inoculation, and two samples did not have detectable virus at d 21 post-laboratory
inoculation. Cochrane et al. (2015) observed increased efficacy at reducing the amount
of quantifiable RNA in complete swine diet and blood meal as the duration of the study
progressed using a 2% essential oil blend (garlic oleoresin, turmeric oleoresin, capsicum
oleoresin, rosemary extract, and wild oregano essential oils). The maximum efficacy was
14 d post-inoculation and beyond in blood meal and beyond 21 d post-inoculation in
the complete swine diet. In the current study, there was no difference in quantification
of genetic material among the untreated control, CRINA, and VevoVitall treatments
(P > 0.10; Ct = 31.8, 31.8, 31.9, respectively). Overall, a greater quantity of PEDV
RNA was detected in SDPP relative to feed (P < 0.001, Ct = 29.3 ± 0.28 vs. 35.0 ±
0.28, SDPP vs. feed, respectively). The PEDV Ct increased between d 0, 1, 3, 21, and 42
post-laboratory inoculation (P < 0.001; 29.3, 30.7, 31.6, 33.9, and 35.2, respectively).
There was no difference in Ct between d 3, 7, and 14 post-laboratory inoculation (P >
0.05, 31.6, 32.1, and 32.2, respectively).

Infectivity

Upon completion of PCR testing, sixteen samples were strategically selected for
assessment of virus infectivity via a bioassay at Iowa State University. The samples
selected were d 0 negative control, 7 positive control, and 7 combination of CRINA
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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and VevoVitall samples. Each sample consisted of 3 supernatant aliquots that each
were gavaged into a single pig within bioassay room. Six combinations were selected
using swine feed and the combination of CRINA and VevoVitall (d 0, 1, 3, 7, 14, and
21 post-laboratory inoculation) and an additional set of samples was selected using
the combination of CRINA and VevoVitall 7 d after inoculation in SDPP. Positive
control samples included untreated FEED and SDPP samples at d 0, 3, and 21 postlaboratory inoculation as well as d 1 FEED positive control for a total of 7 total positive
control bioassay rooms. The d 0 and d 1 FEED positive control samples were from the
current study, however the other 5 positive control samples were in conjunction with
additional research from our laboratory using identical procedures in which bioassay
controls were shared across projects (Ct = 29.4, 34.1, 31.6, 37.3, 37.8; d 0 SDPP, d 3
FEED, d 3 SDPP, d 21 FEED, d 21 SDPP, respectively).
No PEDV RNA was detected in fecal swabs prior to initiation of the bioassay, and
negative control pigs remained negative for PEDV genetic material for the full length
of the bioassay as assessed by fecal swabs and cecal content collected at necropsy (Table
4). Genetic material was detected in all positive control FEED pigs beginning at 2 dpi,
and viral shedding was observed for the duration of the bioassay. All d 0 post-laboratory
inoculation SDPP positive control pigs were shedding PEDV RNA throughout the
bioassay, and cecal contents were positive for PEDV RNA at necropsy. No d 1 FEED
positive control pigs had detectable RNA in fecal swabs or cecal contents in the second
bioassay. All three d 3 post-laboratory inoculation SDPP positive control pigs began
shedding virus at 2 dpi, whereas the d 3 post-laboratory inoculation FEED positive
controls had no detectable RNA in fecal swabs throughout the bioassay or cecal content
at necropsy. No d 21 post-laboratory inoculation positive control pigs had detectable
virus in fecal swabs or cecal contents. Thus, pigs became infected with PEDV with
both FEED and SDPP at d 0 post-laboratory inoculation, as well as d 3 post-laboratory
inoculation in SDPP.
The d 0 FEED combination of CRINA and VevoVitall pigs (3/3) were shedding PEDV
RNA as detected by fecal swabs beginning on 2 dpi and remained infected through
necropsy at 7 dpi. Virus shedding was observed in fecal swabs in one d 7 post-bioassay
inoculation SDPP COMBINATION pig 2 dpi, and all three pigs were shedding
virus at 6 dpi and had virus detectable in cecal contents at necropsy. None of the
COMBINATION treated FEED had detectable RNA in fecal swabs or cecal contents
with the exception of d 0 post-laboratory inoculation samples.
In summary, the combination of CRINA and VevoVitall enhanced degradation
of PEDV RNA in swine feed, but had no impact on RNA degradation in SDPP.
Furthermore, both untreated feed and feed treated with the combination of CRINA
and VevoVitall resulted in PEDV infection at d 0 post-laboratory inoculation; however,
neither set of samples were infective at d 1 post-laboratory inoculation.

Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 1. Diet composition (as-fed basis)1
Item
Ingredient, %
Corn
Soybean meal, 46.5% CP
Monocalcium phosphate, 21% P
Calcium carbonate
Salt
L-Thr
Trace mineral premix1
Sow add pack2
Vitamin premix3
Phytase4
Total

Swine gestation diet
80.40
15.60
1.40
1.15
0.50
0.03
0.15
0.50
0.25
0.02
100

Calculated analysis, %
CP
Crude fiber
Ether extract
Ca
P
Available P

14.1
2.2
3.0
0.85
0.62
0.46

Each kilogram contains 26.4 g Mn, 110 g Fe, 110 g Zn, 11 g Cu, 198 mg I, and 198 mg Se.
Each kilogram contains 110,000 mg choline, 44 mg biotin, 330 mg folic acid, 990 mg pyridoxine.
3
Each kilogram contains 4,400,000 IU vitamin A, 660,000 IU vitamin D3, 17,600 IU vitamin E, 1,760 mg
menadione, 3,300 mg riboflavin, 11,000 mg pantothenic acid, 19,800 mg niacin, 15.4 mg vitamin B12.
4
HiPhos 2700, DSM Nutritional Products, Parsippany, NJ.
1
2

Kansas State University Agricultural Experiment Station and Cooperative Extension Service
8

Swine Day 2016

Table 2. Interactive means of VevoVitall and/or CRINA, matrix, and day, matrix by day
interaction, and main effect of day on PEDV detection as determined by qRT-PCR1
qRT-PCR Ct, Day post-inoculation
Item
0
1
3
7
14
21
42
2
Matrix × treatment × day
FEED
No treatment
29.4
32.5
31.9
35.2
35.8
37.2
39.3(2/3)
CRINA
30.0
32.8
33.3
34.1
35.5
37.7
38.3
VevoVitall
29.8
31.7
33.5
33.4
35.6
38.0
40.4(2/3)
CRINA + VevoVitall
30.2
32.4
33.6
36.0
35.5
42.6(1/3) 45.0(0/3)
SDPP
No treatment
28.7
29.5
29.7
29.1
28.9
28.3
29.4
CRINA
28.4
29.3
29.3
29.1
28.2
30.3
29.4
VevoVitall
28.8
28.6
30.5
28.8
29.0
28.5
30.2
CRINA + VevoVitall
29.1
29.1
31.1
30.7
29.2
28.3
29.7
3
Matrix × day
FEED
29.8e,f
32.3d
33.1d
34.7c
35.6c
38.9b
40.7a
SDPP
28.8f
29.1e,f
30.2e
29.4e,f
28.8f
28.9f
29.7e,f
Day4
29.3e
30.7d
31.6c
32.1c
32.2c
33.9b
35.2a
An initial tissue culture (2.5 mL diluted virus inoculum, 105 TCID50/mL) was inoculated into 22.5 grams of gestation
diet (FEED) or spray-dried porcine plasma (SDPP) treated with 200 ppm CRINA, 5,000 ppm VevoVitall, combination of
CRINA and VevoVitall (COMBINATION) (DSM Nutritional Products, Parsippany, NJ), or no feed additive treatment.
Values are represented by mean quantified PEDV RNA cycle threshold (Ct) value as determined by qRT-PCR.
(X/X)
Superscripts denote number of samples with cycle threshold for PEDV RNA below detectable limit of Ct = 45. A
value of 45.0 was used for assumed for samples with non-detectable RNA for analysis.
2
Matrix × treatment × day interaction, n = 3 for each value. SEM = 0.90 cycle threshold, P = 0.082.
3
Matrix × day interaction, n = 12 for each value. SEM = 0.50 cycle threshold, P < 0.001.
4
Main effect of day, n = 24 for each value. SEM = 0.38 cycle threshold, P < 0.001.
abcdef
Means within interaction or effect lacking a common superscript differ (P < 0.05).
1

Table 3. Interactive means of feed matrix and treatment, and main effect of treatment on
PEDV detection using qRT-PCR1,2
CRINA +
Item
Control
CRINA
VevoVitall VevoVitall
SEM
P=
Matrix × treatment
FEED3
34.5b
34.5b
34.6b
36.5a
0.37
0.079
4
c
c
c
c
SDPP
29.1
29.1
29.2
29.6
b
b
b
Treatment
31.8
31.8
31.9
33.0a
0.28
0.003
An initial tissue culture (2.5 mL diluted virus inoculum, 105 TCID50/mL) was inoculated into 22.5 grams of gestation diet (FEED) or spray-dried porcine plasma (SDPP) treated with 200 ppm CRINA, 5,000 ppm VevoVitall,
combination of CRINA and VevoVitall (COMBINATION) (DSM Nutritional Products, Parsippany, NJ), or
no feed additive treatment. A total of 168 samples were used for the analysis with each treatment represented by a
mean of n = 21 for the matrix × treatment interaction, and n = 42 for the main effect of treatment.
2
Cycle threshold required to detect genetic material. A higher Ct value is indicative of less genetic material present.
3
Swine gestation diet.
4
Spray-dried porcine plasma (APC Functional Proteins, Ankeny, IA).
a,b,c
Means within interaction or effect lacking common superscript differ (P < 0.05).
1
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Table 4. Effects of VevoVitall and/or CRINA as potential porcine epidemic diarrhea
virus (PEDV) mitigation strategies on PEDV detection from feed, pig fecal swabs, and
cecum contents1
Cecum
2
Fecal swabs
contents
Item
-2 dpi
2 dpi
4 dpi
6 dpi
7 dpi
FEED
No treatment
d 0 no virus
----------d0
--+++
+++
+++
+++
d1
----------d3
----------d 21
----------CRINA + VevoVitall
d0
--+++
+++
+++
+++
d1
----------d3
----------d7
----------d 14
----------d 21
----------SDPP
No treatment
d 0 no virus
----------d0
--+++
+++
+++
+++
d3
--+++
+++
+++
+++
d 21
----------CRINA + VevoVitall
d7
--+-+++++
+++
An initial tissue culture 2.5 mL diluted virus inoculum, 105 TCID50/mL) was inoculated into 22.5 grams of gestation diet (FEED) or spray-dried porcine plasma (SDPP) treated with 200 ppm CRINA, 5,000 ppm VevoVitall,
combination of CRINA and VevoVitall (COMBINATION) (DSM Nutritional Products, Parsippany, NJ), or no
feed additive treatment. The supernatant from each sample was then collected for pig bioassay on the appropriate
day post-laboratory inoculation and preserved until initiation of the bioassay. The supernatant was administered
one time via oral gavage on d 0 to each of three pigs per treatment (10 mL per pig). Pigs were initially 10 d old
initial BW = 7.9 lb.
2
Day post-bioassay inoculation.
1
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